UNICHIP
DEAD

Serial Number

78131082

Owner

Protagen AG

Attorney

STANLEY C. MACEL, III, ESQ.

Filing Date

May 24, 2002

Add to watchlist:

No watchlists yet
View on USPTO

UNICHIP Trademark

Serial Number: 78131082 • Registration: 2840032

UNICHIP is a trademark filed by Protagen AG on May 24, 2002. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Protagen AG (3 trademarks)

Otto-Hahn-Str. 15
DORTMUND 44227 , DE

Entity Type: 99

Trademark Details

Filing Date

May 24, 2002

Registration Date

May 11, 2004

Published for Opposition

July 29, 2003

Cancellation Date

December 17, 2010

Goods & Services

Scientific devices and instruments for the protein-expression in a protein-expression bank, namely, protein-biochips, comprising clones for identification and validation of proteins and encoding nucleicacids together with expression-vectors thereof

Pharmaceutical and veterinarian preparations containing therapeutic proteins, therapeutic nucleicacids, gene and/or cells for health and medical care, namely, for the treatment of allergies, arthritis, cancer, diabetes, diseases of the central nervous system, inflammatory diseases, metabolic disorders, viral diseases; pharmaceutical preparations for use in cardiology and oncology; medical and pharmaceutical products, namely human vaccines, anti-infectives, diagnostic proteins, therapeutic proteins, therapeutic nucleicacids, gene and/or cells; medical, biotechnological and gene-technological products and preparations obtainable by protein-expression-banks and nucleicacid-banks together with expression-vectors, proteomics, proteome-analysis, biochips, comprising proteins and nucleicacids, protein-biochips, arrays for use in or at human beings or animals, namely, proteins; diagnostics and detergents for medical and veterinarian use, namely diagnostic preparations and reagents for clinical or medical laboratory use

Services for chemical, pharmaceutical, biotechnological, diagnostical, analytical, gene-technological, medical laboratories or industrial facilities or research- and development facilities, namely consulting and analysis in the field of chemistry, pharmacy, biotechnology, diagnostic, analytical, gene-technology, bio-informatics, target validation and drug development, by means of nucleicacid- or protein-biochips, protein-expression-banks, nucleicacid-banks, polypeptide or nucleicacid-libraries and arrays, automation, application and use of protein-biochips; consulting and analysis in the field of automation, application and use of proteomics, proteome studies, proteome designs, peptide and protein analytic and identification, purification and characterization, 1D and 2D gele electrophorese, mass spectrometry, robotics for proteomics and protein-expression-banks

Filing History

CANCELLED SEC. 8 (6-YR)
Dec 17, 2010 C8..
CASE FILE IN TICRS
Jun 7, 2007 CFIT
REGISTERED-PRINCIPAL REGISTER
May 11, 2004 R.PR
NOTICE OF ALLOWANCE CANCELLED
Mar 26, 2004 IUCN
Sec. 1(B) CLAIM DELETED
Feb 4, 2004 1.BD
FAX RECEIVED
Feb 3, 2004 FAXX
NOA MAILED - SOU REQUIRED FROM APPLICANT
Oct 21, 2003 NOAM
PUBLISHED FOR OPPOSITION
Jul 29, 2003 PUBO
NOTICE OF PUBLICATION
Jul 9, 2003 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 21, 2003 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 21, 2003 CRFA
PAPER RECEIVED
Mar 21, 2003 MAIL
NON-FINAL ACTION E-MAILED
Sep 29, 2002 GNRT
SEC. 44(D) CLAIM ADDED
May 24, 2002 44DA
Sec. 1(B) CLAIM ADDED
May 24, 2002 1.BA
PAPER RECEIVED
May 24, 2002 MAIL